Sammartano, V.; Antonioli, E.; Buda, G.; Ciofini, S.; Candi, V.; Pengue, L.; Del Giudice, M.L.; Attucci, I.; Bacchiarri, F.; Occhini, U.;
et al. Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network). J. Pers. Med. 2022, 12, 484.
https://doi.org/10.3390/jpm12030484
AMA Style
Sammartano V, Antonioli E, Buda G, Ciofini S, Candi V, Pengue L, Del Giudice ML, Attucci I, Bacchiarri F, Occhini U,
et al. Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network). Journal of Personalized Medicine. 2022; 12(3):484.
https://doi.org/10.3390/jpm12030484
Chicago/Turabian Style
Sammartano, Vincenzo, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini,
and et al. 2022. "Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network)" Journal of Personalized Medicine 12, no. 3: 484.
https://doi.org/10.3390/jpm12030484
APA Style
Sammartano, V., Antonioli, E., Buda, G., Ciofini, S., Candi, V., Pengue, L., Del Giudice, M. L., Attucci, I., Bacchiarri, F., Occhini, U., Pirrotta, M. T., Perfetto, F., Bocchia, M., & Gozzetti, A.
(2022). Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network). Journal of Personalized Medicine, 12(3), 484.
https://doi.org/10.3390/jpm12030484
